Skip to main content
. 2021 Nov 17;12:738427. doi: 10.3389/fendo.2021.738427

Table 1.

Clinical and laboratory characteristics of participants by different glucose metabolic state and time to glucose peak at baseline.

Variables G1 (n = 21) G2 (n = 95) G3 (n = 10) p for linear trend
Age 26 (25,33) a 32 (25,39) b 44 (37,47) c <0.001
Male 28.6% (6) 41.1% (39) 50% (5) 0.449
BMI (kg/m2) 21.28 (19.79,23.05) a 23.03 (21.22,25.00) b 25.20 (23.31,28.70) c 0.001
WHR 0.80 (0.75,0.84) 0.82 (0.77,0.87) b 0.92 (0.84,1.01) c <0.001
BTR 0.52 (0.49,0.57) a 0.57 (0.52,0.61) 0.58 (0.56,0.59) 0.090
SBP (mmHg) 112.67 (103.33,121.33) 115 (106,123) 120 (109,132) 0.218
DBP (mmHg) 73.00 (64.67,76.33) 72 (66,83) 75 (70,85) 0.121
ALT (U/L) 10 (9,20) 17 (13,25) 26 (16,31) 0.179
AST (U/L) 16 (13,19) 19 (15,24) 26 (21,33) 0.703
SCr (umol/L) 68 (59,75) 66 (59,80) 69 (56,78) 0.993
UA (umol/L) 279 (269,352) 307 (247,381) 337 (302,373) 0.242
TC (mmol/L) 4.77 ± 0.65 4.55 ± 0.91 b 5.36 ± 0.69 0.082
TG (mmol/L) 0.86 (0.52,1.29) 0.86 (0.59,1.46) b 1.63 (1.08,2.96) c <0.001
HDL-C (mmol/L) 1.44 ± 0.40 a 1.28 ± 0.30 1.12 ± 0.25 c 0.009
LDL-C (mmol/L) 2.64 ± 0.50 2.71 ± 0.78 3.18 ± 0.64 0.068
HbA1c (%) 5.10 (5.00,5.20) 5.10 (5.00,5.40) b 6.05 (5.50,6.60) c <0.001

Data are presented as mean ± SD or as median (interquartile range) or percentage (number).

BMI, body mass index; WHR, waist-to-hip ratio; BTR, biceps-to-thigh ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine transaminase; AST, aspartate aminotransferase; SCr, serum creatinine; UA, uric acid; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1c.

a

Difference between group 1 and group 2 was statistically significant (p1–2 < 0.05).

b

Difference between group 2 and group 3 was statistically significant (p2–3 < 0.05).

c

Difference between group 1 and group 3 was statistically significant (p1–3 < 0.05).

P values < 0.05 were shown in bold.